Turn Therapeutics Inc. (TTRX)
$10.60-4.59%Close
SELLCRISIS · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $316M
- Beta
- 2.05
- P/E (TTM)
- -36.38
- Short % float
- 2.48%
- Days to cover
- 1.3
- SI change
- +74.1%
- 1W
- -8.93%
- 1M
- -21.19%
- vs SPY 1W
- -8.80%
- vs SPY 1M
- -23.70%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 5
- VALUE
- 0
- GROWTH
- 32
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-168.2%
REV YoY-
ROE-280.4%
EPS YoY-
ROA-49.8%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-36.38
P/E FWD-
SECTOR PE20.34
INDUSTRY PE13.84
P/B459.69
P/FCF-
EV/EBITDA-74.77
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E891.13
ALTMAN Z-
CURR RATIO1.19
ND/EBITDA-
BETA2.05
Company news
FAQ
- What is LOPJLB’s current signal on TTRX?
- LOPJLB’s latest quantitative signal on Turn Therapeutics Inc. (TTRX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TTRX in?
- Turn Therapeutics Inc. (TTRX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Turn Therapeutics Inc. (TTRX) do?
- Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wou…